Jiang Yu

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial.

Ocular biometric measurements can help to risk-stratify patients with early angle closure for more severe disease.

Anatomic Changes and Predictors of Angle Widening after Laser Peripheral Iridotomy: The Zhongshan Angle Closure Prevention Trial.

Superior LPI location results in significantly greater angle widening compared with temporal or nasal locations in a Chinese population with PACS. This supports consideration of superior LPI locations to optimize anatomic changes after LPI.

Biometric Risk Factors for Angle Closure Progression After Laser Peripheral Iridotomy.

Study results suggest that persistent angle narrowing detected by AS-OCT or cumulative gonioscopy score was predictive of disease progression in PACS eyes after LPI.

Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population.

Our data has shown a medium level of persistence to topical glaucoma medication among middle-aged and older Australian adults. However, efforts are still needed to improve the rate of persistence.

Role of Static and Dynamic Ocular Biometrics Measured in the Dark and Light as Risk Factors for Angle Closure Progression.

Static parameters measured in the light are as predictive, and possibly more so, of angle closure progression as those measured in the dark.